Recombinant Human A2ML1 Protein, Glycoengineered Human Cell Lines (CAT#: GLJF-0622-JF203)

Product Overview	Recombinant human A2ML1 protein (NP_001269353.1) is produced in Glycoengineered Human Cell Lines. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications.
Source	Glycoengineered Human Cell Lines
Species	Human
Tag	His-tag, FC-tag
Purity	>90%, determined by SDS-PAGE.
Endotoxin Level	Regular batch
Conjugation	None

Target	A2ML1
Full Name	Alpha-2-macroglobulin-like protein 1
Gene ID	144568
Uniprot ID	A8K2U0
Accession Number	NP_001269353.1
Background	This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888).
Alternate Names	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9; A2ML1; CPAMD9